Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Drug Resistance

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 18 articles: HTML format

Single Articles

April 2026
1. CUTHBERTSON BH, Billot L, Campbell MK, Daneman N, et al
   Selective Decontamination of the Digestive Tract during Ventilation in the ICU.
   N Engl J Med. 2026;394:1491-1502.
   PubMed     Abstract available
   
   
   February 2026
2. PUOPOLO KM
   Group B Streptococcal Disease.
   N Engl J Med. 2026;394:896-905.
   PubMed     Abstract available
   
   
   January 2026
3. HOWIE RL, Sharma S, Kyle JL, Rubis AB, et al
   Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance.
   N Engl J Med. 2026;394:199-201.
   PubMed    
   
   
   December 2025
4. PEARL A, Karaba SM, Uhlemann AC
   Contact Precautions for MRSA and Vancomycin-Resistant Enterococcus.
   N Engl J Med. 2025;393:2475-2477.
   PubMed    
   
   
   June 2025
5. HOEFER A, Seth-Smith H, Palma F, Schindler S, et al
   Corynebacterium diphtheriae Outbreak in Migrant Populations in Europe.
   N Engl J Med. 2025;392:2334-2345.
   PubMed     Abstract available
   
   
   April 2025
6. MONTO AS, Kuhlbusch K, Bernasconi C, Cao B, et al
   Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
   N Engl J Med. 2025;392:1582-1593.
   PubMed     Abstract available
   
   
   January 2025
7. GUGLIELMETTI L, Khan U, Velasquez GE, Gouillou M, et al
   Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
   N Engl J Med. 2025;392:468-482.
   PubMed     Abstract available
   
   
   August 2024
8. O'BRIEN KS, Arzika AM, Amza A, Maliki R, et al
   Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.
   N Engl J Med. 2024;391:699-709.
   PubMed     Abstract available
   
   
   
9. GOLDMANN D, Rajan S, Udayakumar K
   Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach.
   N Engl J Med. 2024;391:681-685.
   PubMed    
   
   
   
10. MAITLAND K, Walker AS
    Why Was the Azithromycin "for Life" Trial Necessary?
    N Engl J Med. 2024;391:760-762.
    PubMed    
    
    
    June 2024
11. LIEBERMAN NAP, Reid TB, Cannon CA, Nunley BE, et al
    Near-Universal Resistance to Macrolides of Treponema pallidum in North America.
    N Engl J Med. 2024;390:2127-2128.
    PubMed    
    
    
    May 2024
12. WAGENLEHNER FM, McGovern PC, Moeck G
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection. Reply.
    N Engl J Med. 2024;390:1938-1939.
    PubMed    
    
    
    
13. MANESH A, Varghese GM, Paterson DL
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1938.
    PubMed    
    
    
    
14. VAN OS W, Zeitlinger M
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1937-1938.
    PubMed    
    
    
    
15. LANINI S, Cai T, Tascini C
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:1937.
    PubMed    
    
    
    February 2024
16. WAGENLEHNER FM, Gasink LB, McGovern PC, Moeck G, et al
    Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    N Engl J Med. 2024;390:611-622.
    PubMed     Abstract available
    
    
    
17. STRONG N, Meeks G, Sheth SA, McCullough L, et al
    Neurovascular Complications of Iatrogenic Fusarium solani Meningitis.
    N Engl J Med. 2024;390:522-529.
    PubMed     Abstract available
    
    
    September 2023
18. MORELLO W, Baskin E, Jankauskiene A, Yalcinkaya F, et al
    Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux.
    N Engl J Med. 2023;389:987-997.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum